BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22843703)

  • 1. Developmental basis for filamin-A-associated myxomatous mitral valve disease.
    Sauls K; de Vlaming A; Harris BS; Williams K; Wessels A; Levine RA; Slaugenhaupt SA; Goodwin RL; Pavone LM; Merot J; Schott JJ; Le Tourneau T; Dix T; Jesinkey S; Feng Y; Walsh C; Zhou B; Baldwin S; Markwald RR; Norris RA
    Cardiovasc Res; 2012 Oct; 96(1):109-19. PubMed ID: 22843703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Filamin-a-related myxomatous mitral valve dystrophy: genetic, echocardiographic and functional aspects.
    Lardeux A; Kyndt F; Lecointe S; Marec HL; Merot J; Schott JJ; Le Tourneau T; Probst V
    J Cardiovasc Transl Res; 2011 Dec; 4(6):748-56. PubMed ID: 21773876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical experience for prolapse of both atrioventricular valves in a patient with filamin A mutation.
    Hoashi T; Shiraishi I; Ichikawa H
    Cardiol Young; 2015 Feb; 25(2):365-7. PubMed ID: 24521555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Filamin-A as a Balance between Erk/Smad Activities During Cardiac Valve Development.
    Toomer K; Sauls K; Fulmer D; Guo L; Moore K; Glover J; Stairley R; Bischoff J; Levine RA; Norris RA
    Anat Rec (Hoboken); 2019 Jan; 302(1):117-124. PubMed ID: 30288957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Echocardiographic Evaluation of an Unusual Presentation of X-Linked Myxomatous Valvular Dystrophy Caused by Filamin A Mutation.
    Ma PH; Sachdeva R; Wilson EC; Guzzetta NA
    Semin Cardiothorac Vasc Anesth; 2016 Sep; 20(3):240-5. PubMed ID: 27004951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of Axin2 results in impaired heart valve maturation and subsequent myxomatous valve disease.
    Hulin A; Moore V; James JM; Yutzey KE
    Cardiovasc Res; 2017 Jan; 113(1):40-51. PubMed ID: 28069701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine serotonin and transforming growth factor beta 1 signaling mediates spontaneous myxomatous mitral valve disease.
    Disatian S; Orton EC
    J Heart Valve Dis; 2009 Jan; 18(1):44-51. PubMed ID: 19301552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-frame Variants in FLNA Proximal Rod 1 Domain Associate With a Predominant Cardiac Valvular Phenotype.
    Fernández L; Tenorio J; Polo-Vaquero C; Vallespín E; Palomares-Bralo M; García-Miñaúr S; Santos-Simarro F; Arias P; Carnicer H; Giannivelli S; Medina J; Pérez-Piaya R; Solís J; Rodríguez M; Villagrá A; Rodríguez L; Nevado J; Martínez-Glez V; Heath KE; Lapunzina P
    Rev Esp Cardiol (Engl Ed); 2018 Jul; 71(7):545-552. PubMed ID: 29146485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tryptophan hydroxylase 1 expression is increased in phenotype-altered canine and human degenerative myxomatous mitral valves.
    Disatian S; Lacerda C; Orton EC
    J Heart Valve Dis; 2010 Jan; 19(1):71-8. PubMed ID: 20329492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Infiltration of Extra-Cardiac Cells in Myxomatous Valve Disease.
    Sauls K; Toomer K; Williams K; Johnson AJ; Markwald RR; Hajdu Z; Norris RA
    J Cardiovasc Dev Dis; 2015 Sep; 2(3):200-213. PubMed ID: 26473162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging pathogenic mechanisms in human myxomatous mitral valve: lessons from past and novel data.
    Hulin A; Deroanne C; Lambert C; Defraigne JO; Nusgens B; Radermecker M; Colige A
    Cardiovasc Pathol; 2013; 22(4):245-50. PubMed ID: 23261354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the familial cardiac valvular dystrophy gene, filamin-A, during heart morphogenesis.
    Norris RA; Moreno-Rodriguez R; Wessels A; Merot J; Bruneval P; Chester AH; Yacoub MH; Hagège A; Slaugenhaupt SA; Aikawa E; Schott JJ; Lardeux A; Harris BS; Williams LK; Richards A; Levine RA; Markwald RR
    Dev Dyn; 2010 Jul; 239(7):2118-27. PubMed ID: 20549728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome.
    Ng CM; Cheng A; Myers LA; Martinez-Murillo F; Jie C; Bedja D; Gabrielson KL; Hausladen JM; Mecham RP; Judge DP; Dietz HC
    J Clin Invest; 2004 Dec; 114(11):1586-92. PubMed ID: 15546004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms.
    Oyama MA; Elliott C; Loughran KA; Kossar AP; Castillero E; Levy RJ; Ferrari G
    Cardiovasc Pathol; 2020; 46():107196. PubMed ID: 32006823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desert hedgehog-primary cilia cross talk shapes mitral valve tissue by organizing smooth muscle actin.
    Fulmer D; Toomer KA; Glover J; Guo L; Moore K; Moore R; Stairley R; Gensemer C; Abrol S; Rumph MK; Emetu F; Lipschutz JH; McDowell C; Bian J; Wang C; Beck T; Wessels A; Renault MA; Norris RA
    Dev Biol; 2020 Jul; 463(1):26-38. PubMed ID: 32151560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of transforming growth factor-β signaling and extracellular matrix production in myxomatous mitral valves by angiotensin II receptor blockers.
    Geirsson A; Singh M; Ali R; Abbas H; Li W; Sanchez JA; Hashim S; Tellides G
    Circulation; 2012 Sep; 126(11 Suppl 1):S189-97. PubMed ID: 22965982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality imaging and transcriptomics to phenotype mitral valve dystrophy in a unique knock-in Filamin-A rat model.
    Delwarde C; Toquet C; Aumond P; Kayvanjoo AH; Foucal A; Le Vely B; Baudic M; Lauzier B; Blandin S; Véziers J; Paul-Gilloteaux P; Lecointe S; Baron E; Massaiu I; Poggio P; Rémy S; Anegon I; Le Marec H; Monassier L; Schott JJ; Mass E; Barc J; Le Tourneau T; Merot J; Capoulade R
    Cardiovasc Res; 2023 May; 119(3):759-771. PubMed ID: 36001550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac transgenic matrix metalloproteinase-2 expression induces myxomatous valve degeneration: a potential model of mitral valve prolapse disease.
    Mahimkar R; Nguyen A; Mann M; Yeh CC; Zhu BQ; Karliner JS; Lovett DH
    Cardiovasc Pathol; 2009; 18(5):253-61. PubMed ID: 18835790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Filamin A controls matrix metalloproteinase activity and regulates cell invasion in human fibrosarcoma cells.
    Baldassarre M; Razinia Z; Brahme NN; Buccione R; Calderwood DA
    J Cell Sci; 2012 Aug; 125(Pt 16):3858-69. PubMed ID: 22595522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local serotonin mediates cyclic strain-induced phenotype transformation, matrix degradation, and glycosaminoglycan synthesis in cultured sheep mitral valves.
    Lacerda CM; Kisiday J; Johnson B; Orton EC
    Am J Physiol Heart Circ Physiol; 2012 May; 302(10):H1983-90. PubMed ID: 22345569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.